|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/145 | (2006.01) |
| A61K 35/74 | (2015.01) | ||
| A61K 35/76 | (2015.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K 47/26 | (2006.01) | ||
| A61K 47/38 | (2006.01) | ||
| A61P 31/04 | (2006.01) | ||
| A61P 31/12 | (2006.01) | ||
| A61P 31/16 | (2006.01) | ||
| A61K 9/19 | (2006.01) | ||
| A61K 39/05 | (2006.01) | ||
| A61K 39/08 | (2006.01) |
| (11) | Number of the document | 2689785 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13189570.8 |
| Date of filing the European patent application | 2011-04-15 | |
| (97) | Date of publication of the European application | 2014-01-29 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-19 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 324542 P | 2010-04-15 | US |
| (72) |
NAGATA, Ryoichi, JP
HARUTA, Shunji, JP
|
| (73) |
Shin Nippon Biomedical Laboratories, Ltd.,
2438, Miyanoura-cho Kagoshima-shi, Kagoshima 891-1394,
JP
KM Biologics Co., Ltd., 1-6-1 Okubo, Kita-ku, Kumamoto-shi,, Kumamoto 860-8568, JP |
| (54) | Method for generating dry vaccine powder formulation for inranasal delivery |
| Method for generating dry vaccine powder formulation for inranasal delivery |